Wikipedia -WSS

Wikipedia

author：explore 2025-10-02 19:19:27 - browse：5668

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the first quarter:

In December, Vertex Pharmaceuticalsannounced results from a mid-stage clinical trial showing its experimental, non-opioid drug reduced pain in people with diabetes who have chronic pain. This quarter, the company will read out results from Phase 3 studies of the same pain drug, called VX-548, in people with acute pain following surgery.

The next big test of Alnylam Pharmaceuticals’pipeline of RNA-interference medicines looms with the outcome of a Phase 3 study called HELIOS-B that is investigating vutrisiran as a treatment for ATTR-CM, a progressive disease that leads to heart failure.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： Inequities make cancer less preventable for women: report

WSS

Researchers use wearables data and AI to predict preterm birth risk

WHO recommends dropping component of many flu vaccines

Senator probes 340B programs at Cleveland Clinic, Bon Secours

Hearing on Medicare drug price negotiation gets unusually heated

CommonSpirit Health keeps growing, even as it loses money

Covid vaccines: Private market messier than government rollout

hotspot

Wikipedia

hotspot

The high cost of giving birth even with insurance

Microbiome research is starting to find links to chronic diseases

Wildfire smoke exposes gaps in outdoor worker protections

Intercept Pharmaceuticals sells itself for less than $1 billion

Jerome Adams on the need for new antivirals for Covid

Intercept Pharmaceuticals sells itself for less than $1 billion

Jerome Adams on the need for new antivirals for Covid

Changes to biosimilar regulatory framework must prioritize patients

BioMarin wins approval for gene therapy to treat hemophilia A

Medicaid, Medicare dual

explore

Mindstrong's demise and the future of mental health care

How Vertex's cystic fibrosis drug is changing patients' lives

It's been 20 years since Dolly the sheep. Where's my clone?

FDA seeks to regulate lab

Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds

Did you have Obamacare on your GOP debate bingo card?

Wikipedia

leisure time

explore

hotspot